These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37553850)

  • 41. The implementation of an enhanced clinical model to improve the diagnostic yield of exome sequencing for patients with a rare genetic disease: A Canadian experience.
    Ediae GU; Lemire G; Chisholm C; Hartley T; Eaton A; Osmond M; Rojas SK; Huang L; Gillespie M; ; Sawyer SL; Boycott KM
    Am J Med Genet A; 2023 Feb; 191(2):338-347. PubMed ID: 36331261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances in neurometabolic diseases: The genetic role in the modern era.
    Tein I
    Epilepsy Behav; 2023 Aug; 145():109338. PubMed ID: 37453291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. OMIXCARE: OMICS technologies solved about 33% of the patients with heterogeneous rare neuro-developmental disorders and negative exome sequencing results and identified 13% additional candidate variants.
    Colin E; Duffourd Y; Tisserant E; Relator R; Bruel AL; Tran Mau-Them F; Denommé-Pichon AS; Safraou H; Delanne J; Jean-Marçais N; Keren B; Isidor B; Vincent M; Mignot C; Heron D; Afenjar A; Heide S; Faudet A; Charles P; Odent S; Herenger Y; Sorlin A; Moutton S; Kerkhof J; McConkey H; Chevarin M; Poë C; Couturier V; Bourgeois V; Callier P; Boland A; Olaso R; Philippe C; Sadikovic B; Thauvin-Robinet C; Faivre L; Deleuze JF; Vitobello A
    Front Cell Dev Biol; 2022; 10():1021785. PubMed ID: 36393831
    [No Abstract]   [Full Text] [Related]  

  • 44. Phenotype-driven approaches to enhance variant prioritization and diagnosis of rare disease.
    Jacobsen JOB; Kelly C; Cipriani V; Research Consortium GE; Mungall CJ; Reese J; Danis D; Robinson PN; Smedley D
    Hum Mutat; 2022 Aug; 43(8):1071-1081. PubMed ID: 35391505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expediting rare disease diagnosis: a call to bridge the gap between clinical and functional genomics.
    Hartin SN; Means JC; Alaimo JT; Younger ST
    Mol Med; 2020 Nov; 26(1):117. PubMed ID: 33238891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases.
    Salfati EL; Spencer EG; Topol SE; Muse ED; Rueda M; Lucas JR; Wagner GN; Campman S; Topol EJ; Torkamani A
    Genome Med; 2019 Dec; 11(1):83. PubMed ID: 31847883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiomics technologies: role in disease biomarker discoveries and therapeutics.
    Dar MA; Arafah A; Bhat KA; Khan A; Khan MS; Ali A; Ahmad SM; Rashid SM; Rehman MU
    Brief Funct Genomics; 2023 Apr; 22(2):76-96. PubMed ID: 35809340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multi-omics approaches to disease.
    Hasin Y; Seldin M; Lusis A
    Genome Biol; 2017 May; 18(1):83. PubMed ID: 28476144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attaining Diagnostic Excellence: How the Structure and Function of a Rare Disease Service Contribute to Ending the Diagnostic Odyssey.
    Bordini BJ; Walsh RD; Basel D; Deshmukh T
    Med Clin North Am; 2024 Jan; 108(1):1-14. PubMed ID: 37951644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Next-generation sequencing applied to rare diseases genomics.
    Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
    Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Omics technologies in poultry health and productivity - part 1: current use in poultry research.
    Dehau T; Ducatelle R; Van Immerseel F; Goossens E
    Avian Pathol; 2022 Oct; 51(5):407-417. PubMed ID: 35675291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overview of Systems Biology and Omics Technologies.
    Karahalil B
    Curr Med Chem; 2016; 23(37):4221-4230. PubMed ID: 27686657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-cell multi-omics sequencing and its application in tumor heterogeneity.
    Sun Y; Liu Z; Fu Y; Yang Y; Lu J; Pan M; Wen T; Xie X; Bai Y; Ge Q
    Brief Funct Genomics; 2023 Jul; 22(4):313-328. PubMed ID: 37078714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applications of Omics Technologies for Three-Dimensional
    Pieters VM; Co IL; Wu NC; McGuigan AP
    Tissue Eng Part C Methods; 2021 Mar; 27(3):183-199. PubMed ID: 33406987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.
    Tetreault M; Bareke E; Nadaf J; Alirezaie N; Majewski J
    Expert Rev Mol Diagn; 2015 Jun; 15(6):749-60. PubMed ID: 25959410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in understanding the molecular genetic basis of mitochondrial disease.
    Thompson K; Collier JJ; Glasgow RIC; Robertson FM; Pyle A; Blakely EL; Alston CL; Oláhová M; McFarland R; Taylor RW
    J Inherit Metab Dis; 2020 Jan; 43(1):36-50. PubMed ID: 31021000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing genome sequencing technologies to improve rare disease diagnostics: a protocol for the evaluation of a pilot project, Genome-wide Sequencing Ontario.
    Hayeems RZ; Marshall CR; Gillespie MK; Szuto A; Chisholm C; Stavropoulos DJ; Venkataramanan V; Tsiplova K; Sawyer S; Price EM; Lau L; Khan R; Lee W; Huang L; Jarinova O; Ungar WJ; Mendoza-Londono R; Somerville MJ; Boycott KM
    CMAJ Open; 2022; 10(2):E460-E465. PubMed ID: 35609929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CNV Detection from Exome Sequencing Data in Routine Diagnostics of Rare Genetic Disorders: Opportunities and Limitations.
    Royer-Bertrand B; Cisarova K; Niel-Butschi F; Mittaz-Crettol L; Fodstad H; Superti-Furga A
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA).
    Schuermans N; Hemelsoet D; Terryn W; Steyaert S; Van Coster R; Coucke PJ; Steyaert W; Callewaert B; Bogaert E; Verloo P; Vanlander AV; Debackere E; Ghijsels J; LeBlanc P; Verdin H; Naesens L; Haerynck F; Callens S; Dermaut B; Poppe B;
    Orphanet J Rare Dis; 2022 May; 17(1):210. PubMed ID: 35606766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive use of extended exome analysis improves diagnostic yield in rare disease: a retrospective survey in 1,059 cases.
    Bergant G; Maver A; Lovrecic L; Čuturilo G; Hodzic A; Peterlin B
    Genet Med; 2018 Mar; 20(3):303-312. PubMed ID: 28914264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.